SANYO and BD Biosciences Collaborate for Life Sciences Markets

The two businesses will jointly promote cutting-edge life science research tools designed to advance cell culture and cell therapy research to expand their presence in the cell therapy, cell culture and overall life sciences markets.

SANYO North America Corporation Biomedical Solutions Division and BD Biosciences, a segment of BD (Becton, Dickinson and Company), have announced a strategic agreement to jointly promote cutting-edge life science research tools designed to advance cell culture and cell therapy research, which will help them expand their presence in the cell therapy, cell culture and overall life sciences markets.

The goals of this collaboration are to develop long-term and short-term co-marketing programs, as well as to research innovative ways to combine product technologies and offerings to serve both current and untapped market applications. SANYO will integrate with BD Biosciences' SySTEMatic ExCELLence(SM) marketing campaign.

The two businesses will work toget